跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
盐酸多柔比星脂质体注射液 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Doxorubicin Hydrochloride Liposome Injection
Approved
化学药品
Doxorubicin Hydrochloride Liposome Injection
NATCO PHARMA LIMITED
🇨🇳 National Medical Products Administration
Approval Date
Jun 28, 2024
Approval ID
8bLXyrTfVKJ
Company
NATCO PHARMA LIMITED
Type
化学药品
Approval Details
Approval Id
8bLXyrTfVKJ
Approval Number
国药准字HJ20240056
Generic Name
盐酸多柔比星脂质体注射液
Generic Name En
Doxorubicin Hydrochloride Liposome Injection
Drug Type
化学药品
Dosage Form
注射剂
Strength
25ml : 50mg
Reg Date
2024-06-28
Expired Date
2029-06-27
Company Name
NATCO PHARMA LIMITED
Production Company Name
NATCO PHARMA LIMITED
Company Detail Path
/organization/natco-pharma-limited
Production Company Detail Path
/organization/natco-pharma-limited
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jun 28, 2024
Approval ID
8bLXyrTfVKJ
Type
化学药品
Back to NMPA Approvals
